PL1881824T3 - Zastosowanie triglicerydów kwasu dokozaheksaenowego w leczeniu chorób nowotworowych - Google Patents
Zastosowanie triglicerydów kwasu dokozaheksaenowego w leczeniu chorób nowotworowychInfo
- Publication number
- PL1881824T3 PL1881824T3 PL06754856T PL06754856T PL1881824T3 PL 1881824 T3 PL1881824 T3 PL 1881824T3 PL 06754856 T PL06754856 T PL 06754856T PL 06754856 T PL06754856 T PL 06754856T PL 1881824 T3 PL1881824 T3 PL 1881824T3
- Authority
- PL
- Poland
- Prior art keywords
- docosahexaenoic
- triglycerides
- treatment
- tumorous diseases
- tumorous
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 150000003626 triacylglycerols Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200501141A ES2264886B1 (es) | 2005-05-12 | 2005-05-12 | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
| EP06754856.0A EP1881824B1 (en) | 2005-05-12 | 2006-04-26 | Use of docosahexaenoic triglycerides for the treatment of tumorous diseases |
| PCT/EP2006/061833 WO2006120120A1 (en) | 2005-05-12 | 2006-04-26 | Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1881824T3 true PL1881824T3 (pl) | 2015-06-30 |
Family
ID=36809521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06754856T PL1881824T3 (pl) | 2005-05-12 | 2006-04-26 | Zastosowanie triglicerydów kwasu dokozaheksaenowego w leczeniu chorób nowotworowych |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20080207947A1 (enExample) |
| EP (1) | EP1881824B1 (enExample) |
| JP (2) | JP5893235B2 (enExample) |
| CA (1) | CA2614192C (enExample) |
| DK (1) | DK1881824T3 (enExample) |
| ES (2) | ES2264886B1 (enExample) |
| IL (1) | IL187274A (enExample) |
| NO (1) | NO336953B1 (enExample) |
| NZ (1) | NZ563301A (enExample) |
| PL (1) | PL1881824T3 (enExample) |
| PT (1) | PT1881824E (enExample) |
| WO (1) | WO2006120120A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2264886B1 (es) * | 2005-05-12 | 2008-02-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
| CN101262863B (zh) * | 2005-07-08 | 2016-08-31 | Dsmip资产公司 | 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸 |
| ES2277557B1 (es) | 2005-12-21 | 2008-07-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo. |
| KR101256448B1 (ko) | 2005-12-21 | 2013-04-19 | 브루디 테크놀로지 에스엘 | 세포의 산화적 손상과 연관된 병리상태를 치료하기 위한ｄｈａ, ｅｐａ 또는 ｄｈａ 유래의 ｅｐａ의 용도 |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| CA2708679C (en) * | 2007-12-19 | 2016-11-15 | Prometic Biosciences Inc. | Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| WO2011103514A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha triglyceride emulsions |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| WO2011103510A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha ester emulsions |
| EP2599485B1 (en) * | 2010-07-26 | 2019-02-20 | FUJIFILM Corporation | Fat-containing composition and oral formulation containing same |
| ES2753387T3 (es) | 2013-04-22 | 2020-04-08 | Smartfish As | Uso de una composición que comprende aceite de pescado y zumo para el tratamiento y/o tratamiento posterior del cáncer |
| KR101665253B1 (ko) | 2015-06-19 | 2016-10-25 | 순천향대학교 산학협력단 | 도코사헥사에노산 및 트리아신 씨를 포함하는 것을 특징으로 하는 자궁내막암 치료 및 예방용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3721137A1 (de) * | 1987-06-26 | 1989-01-05 | Dietl Hans | Fettemulsion zur intravenoesen anwendung |
| US5147854A (en) * | 1990-05-22 | 1992-09-15 | Hoffmann-La Roche Inc. | Tgf-b compositions and method |
| JP2572692B2 (ja) * | 1991-07-24 | 1997-01-16 | ボーソー油脂 株式会社 | ドコサヘキサエン酸トリグリセリドの製造法 |
| JPH05139968A (ja) * | 1991-11-14 | 1993-06-08 | Sagami Chem Res Center | メダラシン活性促進剤 |
| JPH0616548A (ja) * | 1992-06-30 | 1994-01-25 | Sagami Chem Res Center | 組織異常増殖抑制剤 |
| JPH06116585A (ja) * | 1992-10-09 | 1994-04-26 | Kanegafuchi Chem Ind Co Ltd | 油脂の精製方法 |
| JP3526632B2 (ja) * | 1994-08-22 | 2004-05-17 | 旭化成ケミカルズ株式会社 | 高度不飽和脂肪酸含有油脂 |
| JPH1057086A (ja) * | 1996-08-20 | 1998-03-03 | Asahi Chem Ind Co Ltd | 高濃度ドコサヘキサエン酸モノグリセリドの製造方法 |
| AU5928599A (en) * | 1999-09-09 | 2001-04-10 | Efa Sciences Llc. | Methods for treating cell proliferative disorders including cancer |
| JP2002180082A (ja) * | 2000-12-11 | 2002-06-26 | Maruha Corp | 摂取物 |
| US20040052837A1 (en) * | 2002-06-27 | 2004-03-18 | William Stillwell | Lipid conjugated anti-cancer drugs and methods of use thereof |
| ES2264886B1 (es) * | 2005-05-12 | 2008-02-01 | Proyecto Empresarial Brudy, S.L. | Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales. |
-
2005
- 2005-05-12 ES ES200501141A patent/ES2264886B1/es not_active Expired - Lifetime
-
2006
- 2006-04-26 NZ NZ563301A patent/NZ563301A/en not_active IP Right Cessation
- 2006-04-26 PL PL06754856T patent/PL1881824T3/pl unknown
- 2006-04-26 WO PCT/EP2006/061833 patent/WO2006120120A1/en not_active Ceased
- 2006-04-26 EP EP06754856.0A patent/EP1881824B1/en active Active
- 2006-04-26 PT PT06754856T patent/PT1881824E/pt unknown
- 2006-04-26 ES ES06754856.0T patent/ES2531599T3/es active Active
- 2006-04-26 JP JP2008510532A patent/JP5893235B2/ja active Active
- 2006-04-26 CA CA2614192A patent/CA2614192C/en not_active Expired - Fee Related
- 2006-04-26 DK DK06754856.0T patent/DK1881824T3/en active
- 2006-04-26 US US11/913,994 patent/US20080207947A1/en not_active Abandoned
-
2007
- 2007-11-08 IL IL187274A patent/IL187274A/en active IP Right Grant
- 2007-12-11 NO NO20076382A patent/NO336953B1/no not_active IP Right Cessation
-
2009
- 2009-08-31 US US12/550,780 patent/US9271954B2/en active Active
-
2014
- 2014-06-23 JP JP2014128247A patent/JP6038841B2/ja active Active
-
2016
- 2016-01-25 US US15/005,181 patent/US20170333381A9/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160193175A1 (en) | 2016-07-07 |
| US20170333381A9 (en) | 2017-11-23 |
| CA2614192C (en) | 2014-03-18 |
| IL187274A0 (en) | 2008-06-05 |
| ES2264886B1 (es) | 2008-02-01 |
| EP1881824A1 (en) | 2008-01-30 |
| DK1881824T3 (en) | 2015-02-23 |
| JP5893235B2 (ja) | 2016-03-23 |
| WO2006120120A1 (en) | 2006-11-16 |
| HK1113319A1 (en) | 2008-10-03 |
| CA2614192A1 (en) | 2006-11-16 |
| NZ563301A (en) | 2010-08-27 |
| ES2531599T3 (es) | 2015-03-17 |
| JP2008540484A (ja) | 2008-11-20 |
| IL187274A (en) | 2011-11-30 |
| EP1881824B1 (en) | 2014-12-24 |
| US20080207947A1 (en) | 2008-08-28 |
| NO20076382L (no) | 2008-02-08 |
| US9271954B2 (en) | 2016-03-01 |
| PT1881824E (pt) | 2015-03-26 |
| ES2264886A1 (es) | 2007-01-16 |
| JP6038841B2 (ja) | 2016-12-07 |
| NO336953B1 (no) | 2015-11-30 |
| US20090318553A1 (en) | 2009-12-24 |
| JP2014208677A (ja) | 2014-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| HRP20150175T1 (en) | Means and methods for the treatment of tumorous diseases | |
| ZA200707591B (en) | Dihyrothienopyrimidines for the treatment of inflammatory diseases | |
| SG10201606441SA (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
| SI2056842T1 (sl) | Modificiran galaktosil-ceramid za zdravljenje kancerogenih obolenj | |
| IL187274A0 (en) | Use of docosahexaenoic glycerides for the treatment of tumoral diseases | |
| EP1948298A4 (en) | BIO-INTERVENING THERAPEUTIC TREATMENT FOR HEART DISEASE DISEASES | |
| IL200862A0 (en) | 3-imidazolyl-indoles for the treatment of proliferative diseases | |
| PL2001892T3 (pl) | Imidazolotiazolowe związki do leczenia chorób proliferacyjnych | |
| IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
| IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
| PT2076268E (pt) | Roscovitina para o tratamento de certas doenças císticas | |
| IL213703A (en) | Compounds for the treatment of pain and other diseases | |
| ZA200806095B (en) | Means and methods for the treatment of tumorous diseases | |
| GB0523961D0 (en) | The treatment of ophthalmic diseases | |
| PL1904060T3 (pl) | Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób | |
| HU0500145D0 (en) | Composition for the treatment of oral diseases | |
| GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
| GB0523964D0 (en) | The treatment of ophthalmic diseases | |
| EP1846013A4 (en) | TREATMENT OF SKIN DISEASES | |
| GB0519274D0 (en) | The treatment of neurodegenerative diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| IL177531A0 (en) | Compounds for the treatment of diseases | |
| GB0425073D0 (en) | Compounds for the treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases |